S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
NTRA · Natera, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
$413.82
+8.03
(+1.98%)
● At close: October 21 at 4:00:00 PM EDT
$412.99
-0.39
(-0.09%)
Overnight:
12:21:24 AM EDT
DAY'S RANGE
$413.82
$406.23
$419.83
52-WEEK RANGE
$413.82
$181.00
$437.41
What's happening
- NTRA is up 1.98% today, trading at $413.82. — Live quote
- Volume today (66,269) is well below its 3-month average of 1,496,810. (Finnhub fundamentals)
- Reports earnings on 2026-11-11 (after market close), 20 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.47 actual vs. $-0.50 estimated (+6.7%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 12
Buy 15
Hold 3
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (30 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
NTRA
+77.19%
vs S&P 500
+64.41%
1-YEAR RETURN
NTRA
+115.23%
vs S&P 500
+100.67%
6-MONTH RETURN
NTRA
+106.99%
3-MONTH RETURN
NTRA
+51.93%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.47
Est. $-0.50
BEAT +6.7%
2026-04-26 (Q1 2026)
$-0.60
Est. $-0.55
MISS -9.7%
2026-01-26 (Q4 2025)
$0.36
Est. $-0.52
BEAT +169.1%
2025-10-26 (Q3 2025)
$-0.64
Est. $-0.38
MISS -68.2%
Valuation Measures & Ratios
Enterprise Value4$59.34B
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)22.29
Price / Book721.34
EV4 / Revenue21.92
EV4 / EBITDA—
Profit Margin-7.11%
Operating Margin-10.70%
Return on Equity (ROE8)-11.73%
Return on Assets (ROA9)-8.11%
Avg Volume (3M)1,496,810
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $38.69B | $28.36B | $22.00B | $23.05B | $18.94B |
| P/E | -113.62 | -83.30 | -76.66 | -97.29 | -93.01 |
| Price/Sales | 14.95 | 12.14 | 10.58 | 12.12 | 10.99 |
| Price/Book | 21.24 | 15.99 | 17.57 | 18.50 | 15.28 |
| EV/Revenue | 14.98 | 12.17 | 10.61 | 12.16 | 11.04 |
| EV/EBITDA | -118.53 | -84.47 | -76.44 | — | — |
| ROE | -18.70% | -19.19% | -22.92% | -19.01% | -16.42% |
| ROA | -12.81% | -13.02% | -15.76% | -13.48% | -11.75% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short6,355,450
Change from Prior Settlement+32.48%
% of Float—
Days to Cover (Short Ratio)3.20
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 37.7% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +115.2%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is -7.1%. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-10-20; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on NTRA
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $752.8M | $696.6M | $592.2M | $546.6M | $501.8M | $439.8M | $413.4M | $367.7M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$75.8M | -$93.5M | -$97.6M | -$110.4M | -$79.2M | -$39.3M | -$43.9M | -$74.3M |
| Net income | -$67.0M | -$85.1M | -$87.5M | -$100.9M | -$66.9M | -$31.6M | -$37.5M | -$67.6M |
| EPS (diluted) | $-0.47 | $-0.60 | $-0.64 | $-0.74 | $-0.50 | $-0.26 | $-0.30 | $-0.56 |
| EPS (basic) | $-0.47 | $-0.60 | $-0.64 | $-0.74 | $-0.50 | $-0.26 | $-0.30 | $-0.56 |
| Operating margin | -$10 | -$13 | -$16 | -$20 | -$16 | -$9 | -$11 | -$20 |
| Net margin | -$9 | -$12 | -$15 | -$18 | -$13 | -$7 | -$9 | -$18 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $2.66B | $2.61B | $2.40B | — | $1.82B | $1.76B | $1.73B | $1.66B |
| Total liabilities | $836.0M | $840.4M | $685.9M | — | $569.3M | $510.9M | $492.7M | $465.3M |
| Stockholders' equity | $1.82B | $1.77B | $1.71B | — | $1.25B | $1.25B | $1.24B | $1.20B |
| Total current assets | $1.66B | $1.65B | $1.50B | — | $1.45B | $1.43B | $1.42B | $1.38B |
| Total current liabilities | $553.2M | $558.3M | $441.2M | — | $442.0M | $384.8M | $365.7M | $344.0M |
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Marketable securities (current) | — | — | — | — | $1.0M | $16.0M | $17.8M | $22.7M |
| Accounts receivable | $422.0M | $417.6M | $296.5M | — | $286.4M | $309.2M | $318.2M | $314.2M |
| Inventory | $80.3M | $70.7M | $68.4M | — | $64.6M | $54.3M | $50.4M | $44.7M |
| Property, plant & equipment | $317.6M | $269.4M | $241.2M | — | $206.5M | $189.2M | $180.5M | $162.0M |
| Goodwill | $141.1M | $140.9M | $141.1M | $141.1M | — | — | — | — |
| Intangible assets | $360.2M | $367.4M | $373.7M | — | — | — | — | $10.9M |
| Other non-current assets | $50.0M | $51.0M | $36.9M | — | $70.7M | $41.1M | $40.9M | $25.8M |
| Accounts payable | $75.2M | $62.4M | $33.2M | — | $46.5M | $36.9M | $39.2M | $34.9M |
| Accrued liabilities | — | — | — | — | — | — | — | — |
| Deferred revenue (current) | $40.6M | $36.9M | $24.9M | — | $21.8M | $21.6M | $20.6M | $19.8M |
| Short-term debt | $80.3M | $80.3M | $80.3M | — | $80.3M | $80.3M | $80.3M | $80.4M |
| Other current liabilities | $228.5M | $212.5M | $188.7M | — | $216.0M | $191.0M | $178.4M | $146.9M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Other non-current liabilities | $25.3M | $16.3M | $11.7M | — | — | — | — | $7.8M |
| Common stock & paid-in capital | $14.0K | $14.0K | $14.0K | — | $14.0K | $14.0K | $14.0K | $12.0K |
| Retained earnings | -$2.93B | -$2.86B | -$2.78B | — | -$2.82B | -$2.74B | -$2.63B | -$2.57B |
| Accumulated other comprehensive income (loss) | -$108.0K | -$202.0K | -$258.0K | — | -$187.0K | -$287.0K | -$197.0K | -$344.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $54.8M | $40.2M | $73.9M | $59.4M | $37.6M | $44.5M | $52.9M | $51.8M |
| Investing cash flow | -$63.4M | -$32.1M | -$71.6M | -$19.9M | -$23.9M | -$16.8M | -$11.1M | $42.5M |
| Financing cash flow | $12.2M | $3.8M | $32.4M | $1.9M | $12.6M | $544.0K | $11.0M | $1.7M |
| Free cash flow | -$8.6M | $18.0M | $37.8M | $37.0M | $11.7M | $22.6M | $34.8M | $35.5M |
| Capital expenditures | $63.4M | $22.1M | $36.1M | $22.4M | $25.9M | $21.8M | $18.1M | $16.3M |
| Depreciation & amortization | $15.5M | $14.5M | $12.4M | $10.3M | $9.9M | $9.2M | $7.8M | $8.2M |
| Share-based compensation | $103.1M | $95.1M | $92.6M | $90.6M | $93.4M | $77.8M | $71.9M | $70.6M |
| Change in accounts receivable | $4.4M | $121.1M | $7.0M | -$22.8M | -$9.0M | $4.1M | $7.3M | -$29.1M |
| Change in inventory | $9.6M | $2.3M | $971.0K | $10.4M | $3.9M | $5.6M | -$4.0M | $7.7M |
| Change in accounts payable | $13.7M | $21.9M | -$11.6M | $5.4M | $4.6M | $2.4M | $2.4M | -$5.8M |
| Purchases of investments | — | — | — | — | — | — | $0 | $49.2M |
| Sales/maturities of investments | $0 | $0 | $1.0M | $15.0M | $2.0M | $5.0M | $7.0M | $85.9M |
| Debt issued | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | $5.1M | — | — | — | $0 | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $2.31B | $1.70B | $1.08B | $820.2M | $625.5M |
| Operating income | -$309.9M | -$222.3M | -$446.2M | -$541.0M | -$468.2M |
| Net income | -$208.2M | -$190.4M | -$434.8M | -$547.8M | -$471.7M |
| EPS (diluted) | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 |
| EPS (basic) | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 |
| Operating margin | -$13 | -$13 | -$41 | -$66 | -$75 |
| Net margin | -$9 | -$11 | -$40 | -$67 | -$75 |
Balance sheet
| Line item | Dec '25 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| Total assets | $2.40B | — | $1.66B | $1.44B | $1.39B |
| Total liabilities | $685.9M | — | $465.3M | $676.4M | $688.7M |
| Stockholders' equity | $1.71B | — | $1.20B | $765.3M | $705.7M |
| Total current assets | $1.50B | — | $1.38B | $1.26B | $1.21B |
| Total current liabilities | $441.2M | — | $344.0M | $307.3M | $310.5M |
| Cash & equivalents | — | — | — | — | $466.0M |
| Marketable securities (current) | — | — | $22.7M | $236.9M | $432.3M |
| Accounts receivable | $296.5M | — | $314.2M | $278.3M | $244.4M |
| Inventory | $68.4M | — | $44.7M | $40.8M | $35.4M |
| Property, plant & equipment | $241.2M | — | $162.0M | $111.2M | $92.5M |
| Goodwill | $141.1M | $141.1M | — | — | — |
| Intangible assets | $373.7M | — | $10.9M | — | — |
| Other non-current assets | $36.9M | — | $25.8M | $15.4M | $18.3M |
| Accounts payable | $33.2M | — | $34.9M | $15.0M | $31.1M |
| Accrued liabilities | — | — | — | — | — |
| Deferred revenue (current) | $24.9M | — | $19.8M | $16.6M | $10.8M |
| Short-term debt | $80.3M | — | $80.4M | $80.4M | $80.3M |
| Other current liabilities | $188.7M | — | $146.9M | $149.4M | $144.2M |
| Long-term debt | — | — | — | $282.9M | $281.7M |
| Other non-current liabilities | $11.7M | — | $7.8M | — | — |
| Common stock & paid-in capital | $14.0K | — | $12.0K | $11.0K | $11.0K |
| Retained earnings | -$2.78B | — | -$2.57B | -$2.38B | -$1.94B |
| Accumulated other comprehensive income (loss) | -$258.0K | — | -$344.0K | -$3.1M | -$16.4M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $215.3M | $135.7M | -$247.0M | -$431.5M | -$335.2M |
| Investing cash flow | -$132.2M | $137.6M | $168.5M | $330.3M | -$205.2M |
| Financing cash flow | $47.5M | $30.2M | $254.5M | $482.6M | $576.2M |
| Free cash flow | $109.1M | $69.2M | -$286.2M | -$479.2M | -$376.3M |
| Capital expenditures | $106.2M | $66.4M | $39.2M | $47.7M | $41.0M |
| Depreciation & amortization | $41.8M | $31.0M | $24.1M | $16.7M | $11.3M |
| Share-based compensation | $354.4M | $274.4M | $191.8M | $152.4M | $115.2M |
| Change in accounts receivable | -$20.8M | $35.9M | $33.9M | $122.3M | $43.5M |
| Change in inventory | $20.9M | $4.0M | $5.4M | $8.5M | $6.9M |
| Change in accounts payable | $753.0K | $13.2M | -$15.5M | $5.5M | $19.2M |
| Purchases of investments | — | $122.0M | $98.3M | $86.9M | $876.1M |
| Sales/maturities of investments | $23.0M | $314.4M | $306.0M | $216.5M | $532.9M |
| Debt issued | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding NTRA as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 30 filers
Held by These Filers67.7%
Shares Outstanding143,612,000
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| Jpmorgan Chase & Co | 12,865,346 | $3.51B | 8.96% | -3.9% | 2026-08-12 |
| BlackRock, Inc. | 10,914,608 | $2.96B | 7.60% | +2.2% | 2026-08-07 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 9,021,895 | $2.4M | 6.28% | -26.0% | 2026-08-14 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,228,216 | $1.69B | 4.34% | +3.7% | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5,782,640 | $1.57B | 4.03% | +2.4% | 2026-06-30 |
| FMR LLC | 5,451,396 | $1.48B | 3.80% | +113.4% | 2026-08-13 |
| WELLINGTON MANAGEMENT GROUP LLP | 4,040,738 | $1.10B | 2.81% | -15.3% | 2026-08-14 |
| State Street Corp | 3,655,618 | $992.3M | 2.55% | +7.0% | 2026-08-07 |
| Duquesne Family Office LLC | 3,186,306 | $864.9K | 2.22% | +4.0% | 2026-08-14 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,750,013 | $744.6M | 1.91% | -0.9% | 2026-08-12 |
| Franklin Templeton Inc | 2,725,903 | $739.9M | 1.90% | +9.7% | 2026-08-04 |
| Castle Hook Partners LP | 2,596,276 | $704.8M | 1.81% | +2.6% | 2026-08-14 |
| COATUE MANAGEMENT LLC | 2,505,090 | $680.0M | 1.74% | -1.4% | 2026-08-14 |
| AQR CAPITAL MANAGEMENT LLC | 2,344,570 | $628.1M | 1.63% | +3.1% | 2026-08-14 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 2,218,366 | $602.2M | 1.54% | -30.8% | 2026-08-14 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1,971,391 | $535.1M | 1.37% | -3.4% | 2026-08-03 |
| NORGES BANK | 1,828,122 | $496.2M | 1.27% | +0.0% | 2026-08-12 |
| FRED ALGER MANAGEMENT, LLC | 1,778,009 | $482.6M | 1.24% | +1.2% | 2026-08-14 |
| Goldman Sachs Group Inc | 1,720,152 | $466.9M | 1.20% | +124.2% | 2026-08-14 |
| Sofinnova Investments, Inc. | 1,550,280 | $420.8M | 1.08% | +0.0% | 2026-08-14 |
| Capital World Investors | 1,504,387 | $408.4M | 1.05% | +2.5% | 2026-08-07 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1,503,706 | $408.2M | 1.05% | +26.2% | 2026-08-13 |
| MAVERICK CAPITAL LTD | 1,356,663 | $368.3M | 0.94% | +15.8% | 2026-08-14 |
| D. E. Shaw & Co., Inc. | 1,279,255 | $347.3M | 0.89% | +160.4% | 2026-08-14 |
| Morgan Stanley | 1,274,287 | $345.9M | 0.89% | -5.9% | 2026-08-11 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-07-27 to 2026-10-16
Recent transactions
- Insiders have net sold 289,459 shares over the last 182 days, across 0 purchases and 130 sales.
- Most recent: Sheena Jonathan (Reporting person) — Open market sale of 215 shares on 2026-10-16.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)289,459 sh(130 txns)
Net Shares-289,459
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Sheena Jonathan | Reporting person | Open market sale | 2026-10-16 | 215 |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Option exercise | 2026-10-15 | 50,000 |
| Chapman Steven Leonard | CEO AND PRESIDENT | Open market sale | 2026-10-01 | 1,273 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Open market sale | 2026-10-01 | 200 |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Open market sale | 2026-08-10 | 6,517 |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Open market sale | 2026-08-04 | 478 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Open market sale | 2026-08-03 | 334 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-16 | Sheena Jonathan | Reporting person | Open market sale | 215 | $399.34 |
| 2026-10-16 | Sheena Jonathan | Reporting person | Open market sale | 280 | $401.29 |
| 2026-10-16 | Sheena Jonathan | Reporting person | Open market sale | 90 | $404.25 |
| 2026-10-16 | Sheena Jonathan | Reporting person | Open market sale | 50 | $405.15 |
| 2026-10-16 | Sheena Jonathan | Reporting person | Open market sale | 35 | $406.62 |
| 2026-10-16 | Sheena Jonathan | Reporting person | Open market sale | 80 | $409.36 |
| 2026-10-16 | Sheena Jonathan | Reporting person | Open market sale | 142 | $398.95 |
| 2026-10-16 | Sheena Jonathan | Reporting person | Open market sale | 280 | $400.68 |
| 2026-10-16 | Sheena Jonathan | Reporting person | Open market sale | 60 | $401.62 |
| 2026-10-16 | Sheena Jonathan | Reporting person | Open market sale | 90 | $403.70 |
| 2026-10-16 | Sheena Jonathan | Reporting person | Open market sale | 80 | $406.06 |
| 2026-10-16 | Sheena Jonathan | Reporting person | Open market sale | 98 | $409.34 |
| 2026-10-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Option exercise | 50,000 | $10.41 |
| 2026-10-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Open market sale | 286 | $388.32 |
| 2026-10-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Open market sale | 714 | $389.84 |
| 2026-10-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Open market sale | 600 | $390.21 |
| 2026-10-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Open market sale | 300 | $391.58 |
| 2026-10-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Open market sale | 800 | $393.47 |
| 2026-10-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Open market sale | 300 | $394.39 |
| 2026-10-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Open market sale | 1,900 | $396.30 |
| 2026-10-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Open market sale | 1,100 | $397.16 |
| 2026-10-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Open market sale | 600 | $398.09 |
| 2026-10-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Open market sale | 793 | $399.31 |
| 2026-10-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Open market sale | 2,671 | $400.31 |
| 2026-10-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Open market sale | 5,974 | $401.42 |
| 2026-10-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Open market sale | 6,309 | $402.23 |
| 2026-10-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Open market sale | 3,858 | $403.27 |
| 2026-10-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Open market sale | 10,321 | $404.64 |
| 2026-10-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Open market sale | 6,274 | $405.18 |
| 2026-10-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Open market sale | 1,400 | $406.63 |
| 2026-10-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Open market sale | 3,800 | $407.27 |
| 2026-10-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Open market sale | 2,000 | $408.24 |
| 2026-10-07 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Gift | 6,000 | $0.00 |
| 2026-10-01 | Chapman Steven Leonard | CEO AND PRESIDENT | Open market sale | 1,273 | $413.31 |
| 2026-10-01 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Open market sale | 200 | $411.62 |
| 2026-10-01 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Open market sale | 954 | $413.11 |
| 2026-10-01 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Open market sale | 1,846 | $415.07 |
| 2026-09-23 | Sheena Jonathan | Reporting person | Open market sale | 400 | $385.10 |
| 2026-09-23 | Sheena Jonathan | Reporting person | Open market sale | 2,175 | $386.71 |
| 2026-09-23 | Sheena Jonathan | Reporting person | Open market sale | 2,734 | $387.65 |
| 2026-09-23 | Sheena Jonathan | Reporting person | Open market sale | 1,293 | $388.71 |
| 2026-09-23 | Sheena Jonathan | Reporting person | Open market sale | 2,320 | $389.69 |
| 2026-09-23 | Sheena Jonathan | Reporting person | Open market sale | 110 | $390.42 |
| 2026-09-23 | Sheena Jonathan | Reporting person | Open market sale | 390 | $385.29 |
| 2026-09-23 | Sheena Jonathan | Reporting person | Open market sale | 2,300 | $386.64 |
| 2026-09-23 | Sheena Jonathan | Reporting person | Open market sale | 2,846 | $387.74 |
| 2026-09-23 | Sheena Jonathan | Reporting person | Open market sale | 1,341 | $388.76 |
| 2026-09-23 | Sheena Jonathan | Reporting person | Open market sale | 1,935 | $389.71 |
| 2026-09-23 | Sheena Jonathan | Reporting person | Open market sale | 220 | $390.52 |
| 2026-09-16 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Gift | 945 | $0.00 |
| 2026-09-16 | Sheena Jonathan | Reporting person | Open market sale | 200 | $348.02 |
| 2026-09-16 | Sheena Jonathan | Reporting person | Open market sale | 100 | $349.05 |
| 2026-09-16 | Sheena Jonathan | Reporting person | Open market sale | 1,400 | $353.83 |
| 2026-09-16 | Sheena Jonathan | Reporting person | Open market sale | 450 | $354.91 |
| 2026-09-16 | Sheena Jonathan | Reporting person | Open market sale | 800 | $355.95 |
| 2026-09-16 | Sheena Jonathan | Reporting person | Open market sale | 200 | $356.87 |
| 2026-09-15 | Sheena Jonathan | Reporting person | Open market sale | 6,000 | $350.07 |
| 2026-09-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Open market sale | 1,481 | $339.24 |
| 2026-09-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Open market sale | 2,549 | $340.25 |
| 2026-09-15 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Open market sale | 1,813 | $341.41 |
Showing the most recent 60 transactions.
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 05:36 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-20 | 4 | 2026-10-16 | View on SEC.gov → |
| 2026-10-16 | 4 | 2026-10-15 | View on SEC.gov → |
| 2026-10-09 | 4 | 2026-10-07 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-09-25 | 4 | 2026-09-23 | View on SEC.gov → |
| 2026-09-18 | 4 | 2026-09-16 | View on SEC.gov → |
| 2026-09-17 | 4 | 2026-09-15 | View on SEC.gov → |
| 2026-09-16 | 4 | 2026-09-14 | View on SEC.gov → |
| 2026-09-11 | 4 | 2026-09-11 | View on SEC.gov → |
| 2026-09-03 | 4 | 2026-09-01 | View on SEC.gov → |
| 2026-09-03 | 4 | 2026-09-01 | View on SEC.gov → |
Recent news
Headlines about NTRA (Natera, Inc.). Links open the publisher — we don’t host full articles.
-
$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today
Benzinga · 2026-10-21 -
Natera Director Sheena Jonathan Files to Sell 9,450 Shares Valued at $3.88 Million
Kalkine Media · 2026-10-21 -
After a $7.01M September sale, a Natera (NTRA) director proposes another share sale.
Stock Titan · 2026-10-21 -
How Long Can GeneDx Keep Burning Cash?
Yahoo · 2026-10-21 -
Natera stock: On Xetra, Natera stock rises 3.03 percent
AD HOC NEWS · 2026-10-21 -
NTRA Jan 2027 520.000 put (NTRA270115P00520000) Interactive Stock Chart
Yahoo! Finance Canada · 2026-10-21 -
Natera Partners With TransCode to Advance Colorectal Cancer Trial
Yahoo · 2026-10-21 -
NTRA Jan 2027 440.000 put (NTRA270115P00440000) Interactive Stock Chart
Yahoo! Finance Canada · 2026-10-21
No headlines in this category right now — try “All”.